Serum Dickkopf-4 as a Biomarker for the Diagnosis and Treatment of Gastrointestinal Stromal Tumor
NCT02931981 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2016-10-13
Summary
Our study aims to evaluate the role of Dickkopf-4 as biomarkers in the treatment of gastrointestinal stromal tumor.
Conditions
- Gastrointestinal Stromal Tumor
Interventions
- PROCEDURE
-
surgery or biopsy
Do radical surgery or biopsy to obtain a pathological result
Sponsors & Collaborators
-
RenJi Hospital
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2016-10-31
- Completion
- 2019-10-31
Countries
- China
Study Locations
More Related Trials
-
Targeted Agent Evaluation in Digestive Cancers in China Based on Molecular Characteristics
NCT04584008 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Hyperthermic Intraperitoneal Treatment of rmhTNF for CRCPM: Phase II Clinical Trial
NCT05755685 ·Status: UNKNOWN ·Phase: PHASE2
-
Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer
NCT03573791 ·Status: RECRUITING
-
Diagnosis of Colorectal Cancer and Advanced Adenoma Using Cancer-specific Methylation Signatures
NCT03828396 ·Status: UNKNOWN
-
Prospective Gastric Cancer Screening With Fecal Multi-target DNA Analysis
NCT06943807 ·Status: RECRUITING
-
Clinical Study of Personalized mRNA Vaccine Encoding Neoantigen in Subjects With Resected Digestive System Neoplasms
NCT06026774 ·Status: RECRUITING ·Phase: PHASE1
-
Significance of Circulating Tumor Cells in the Treatment of Gastric and Rectal Cancer
NCT02955173 ·Status: COMPLETED ·Phase: NA
-
Optical Biopsy for Distal Margin in Low Rectal Cancer
NCT04016948 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Value and Clinical Pathology of c-MET Expression and Amplification in Gastric Carcinoma
NCT02002416 ·Status: UNKNOWN
-
Transanal Decompression Tube Versus Stent for Acute Malignant Left-sided Colonic and Rectal Obstruction
NCT02585271 ·Status: TERMINATED ·Phase: NA
-
A Clinical Study on the Safety and Efficacy of CAR-T Therapy for the TM4SF1-positive Tumors of Digestive System
NCT05673434 ·Status: UNKNOWN ·Phase: NA
-
Consistency Between Treatment Responses in PDO Models and Clinical Outcomes in Gastric Cancer
NCT05203549 ·Status: UNKNOWN
-
The Risk of Second Primary Gastrointestinal Malignancies Following Primary Gastrointestinal Carcinoid Tumors: a SEER Based Study 2000-2022
NCT07291752 ·Status: COMPLETED
-
BGT007H Cells for the Treatment of Refractory Digestive System Tumors
NCT06104215 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
ctDNA for Prediction of Relapse in Gastric Cancer
NCT02887612 ·Status: UNKNOWN
-
Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study
NCT06647901 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Ripretinib Combined With Surgery in Advanced GIST That Have Failed Imatinib Therapy: A Multicenter,Observational Study
NCT05354388 ·Status: UNKNOWN
-
Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma
NCT05461235 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
BGT007 Cells for the Treatment of Refractory Digestive System Tumors
NCT06104241 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
BGT007H Cells for the Treatment of Recurrent/Refractory Gastrointestinal Tumors
NCT06152757 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors
NCT05515796 ·Status: COMPLETED ·Phase: PHASE2
-
Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers
NCT05431621 ·Status: COMPLETED
-
ctDNA Methylation Application in Postoperative Relapse and Adjuvant Chemotherapy Efficacy Evaluation
NCT05536089 ·Status: RECRUITING
-
Detect Microsatellite Instability Status in Blood Sample of Advanced Colorectal Cancer Patients by Next-Generation Sequencing
NCT03561350 ·Status: UNKNOWN
-
Combination of Cryosurgey and NK Immunotherapy for Recurrent Laryngeal Cancer
NCT02849314 ·Status: COMPLETED ·Phase: PHASE1/PHASE2